OS‐01 Peptide Topical Formulation Improves Skin Barrier Function and Reduces Systemic Inflammation Markers: A Pilot 12‐Week Clinical Trial

Documenti analoghi

• Double‐blind, vehicle‐controlled clinical investigation of peptide OS‐01 for skin rejuvenation
  di: Alessandra Zonari, et al.
  Pubblicazione: (2024)
• Clinical efficacy of OS‐01 peptide formulation in reducing the signs of periorbital skin aging
  di: Alessandra Zonari, et al.
  Pubblicazione: (2025)
• Efficacy of a Topical Formulation on Skin Hydration and Barrier Function in Individuals With Xerosis: A 28‐Day Randomized, Split‐Leg, Untreated‐Controlled Trial
  di: Daniel Morgado‐Carrasco, et al.
  Pubblicazione: (2026)
• Topical Carboxytherapy Modulates the Skin Microbiome Following CO 2 Laser Resurfacing: A Pilot Study
  di: Barbara Hernandez‐Rovira, et al.
  Pubblicazione: (2026)
• Correction to “A Systemic Pathophysiological View of Sensitive Skin Revealed by Proteomics: Beyond Barrier and Inflammation”
  Pubblicazione: (2026)